CY2154B1 - Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives - Google Patents

Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives

Info

Publication number
CY2154B1
CY2154B1 CY9900019A CY9900019A CY2154B1 CY 2154 B1 CY2154 B1 CY 2154B1 CY 9900019 A CY9900019 A CY 9900019A CY 9900019 A CY9900019 A CY 9900019A CY 2154 B1 CY2154 B1 CY 2154B1
Authority
CY
Cyprus
Prior art keywords
deoxy
acyl
derivatives
fluorocytidine
producing
Prior art date
Application number
CY9900019A
Other languages
English (en)
Inventor
Takashi Kamiya
Makoto Ishiduka
Hiroshi Nakajima
Original Assignee
Fuji Chem Ind Co Ltd
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chem Ind Co Ltd, Hoffmann La Roche filed Critical Fuji Chem Ind Co Ltd
Publication of CY2154B1 publication Critical patent/CY2154B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/073Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CY9900019A 1992-12-18 1999-07-26 Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives CY2154B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92121539 1992-12-18

Publications (1)

Publication Number Publication Date
CY2154B1 true CY2154B1 (en) 2002-08-23

Family

ID=8210305

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9900019A CY2154B1 (en) 1992-12-18 1999-07-26 Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives

Country Status (13)

Country Link
US (1) US5453497A (hr)
EP (1) EP0602478B1 (hr)
JP (2) JP3530218B2 (hr)
KR (1) KR100343481B1 (hr)
CN (1) CN1035675C (hr)
AT (1) ATE140923T1 (hr)
CA (1) CA2110335C (hr)
CY (1) CY2154B1 (hr)
DE (1) DE69303879T2 (hr)
DK (1) DK0602478T3 (hr)
ES (1) ES2093905T3 (hr)
RU (1) RU2131879C1 (hr)
TW (1) TW254946B (hr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476932A (en) * 1994-08-26 1995-12-19 Hoffmann-La Roche Inc. Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives
KR100631754B1 (ko) * 2000-08-09 2006-10-09 주식회사 코오롱 N-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법
WO2003063771A2 (en) 2001-12-14 2003-08-07 Pharmasset Ltd. N4-acylcytosine nucleosides for treatment of viral iinfections
EP1589027A1 (en) * 2003-01-17 2005-10-26 Ajinomoto Co., Inc. Processes for production of nucleosides
DE602004015331D1 (de) 2003-12-22 2008-09-04 Hoffmann La Roche Verfahren für fluorcytidinderivate
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4-氧羰基胞嘧啶衍生物及制备方法与应用
US20050192433A1 (en) * 2004-02-26 2005-09-01 Mitsui Chemicals, Inc. Metallic salt of N4-acylcytidine derivatives, and a method for producing N4-acylcytidine derivatives using the same
JP4627625B2 (ja) * 2004-03-11 2011-02-09 三井化学株式会社 N−アセチルシチジン類の製造方法
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
AU2006210572B2 (en) 2005-02-03 2011-08-04 The General Hospital Corporation Method for treating gefitinib resistant cancer
EP1868608A2 (en) * 2005-04-01 2007-12-26 F. Hoffmann-Roche AG Method for administration of capecitabine
EP3488866A1 (en) 2005-11-04 2019-05-29 Wyeth LLC Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
MX2009011255A (es) * 2007-04-20 2009-11-23 Reddys Lab Ltd Dr Proceso para preparar capecitabina.
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
KR101013312B1 (ko) * 2007-11-19 2011-02-09 한미홀딩스 주식회사 카페시타빈의 제조방법 및 이에 사용되는 β-아노머가강화된 트리알킬카보네이트 화합물의 제조방법
AR064165A1 (es) * 2007-12-06 2009-03-18 Richmond Sa Com Ind Y Financie Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento
US20090209754A1 (en) * 2008-01-03 2009-08-20 Macdonald Peter Lindsay Process for the preparation of capecitabine
PL2562166T3 (pl) * 2008-01-22 2016-01-29 Dow Agrosciences Llc Pochodne 5-fluoropirymidyny jako fungicydy
RU2492860C2 (ru) 2008-06-17 2013-09-20 УАЙТ ЭлЭлСи Антиопластические комбинации, содержащие нкi-272 и винорелбин
PL3175853T3 (pl) 2008-08-04 2024-03-25 Wyeth Llc Przeciwnowotworowe połączenia neratynibu i kapecytabiny
WO2010061402A2 (en) * 2008-11-25 2010-06-03 Vishwanath Kannan An improved process for the preparation of capecitabine
EP2370414A4 (en) * 2008-12-02 2012-11-14 Reddys Lab Ltd Dr PREPARATION OF CAPECITABINE
CN101525362B (zh) * 2009-01-15 2011-05-11 浙江诚意药业有限公司 5’-脱氧-2’,3’-二乙酰-5-氟胞苷的制备方法
PL3000467T3 (pl) 2009-04-06 2023-05-02 Wyeth Llc Schemat leczenia wykorzystujący neratynib dla raka sutka
WO2011010967A1 (en) * 2009-07-23 2011-01-27 Scinopharm Taiwan Ltd. Process for producing flurocytidine derivatives
CN102190695B (zh) * 2010-03-18 2013-12-18 齐鲁制药有限公司 5’-脱氧-2’,3’-二乙酰-5-氟胞苷的制备方法
CN101830952A (zh) * 2010-04-22 2010-09-15 上海柯林斯堡医药科技有限公司 2’,3’-o-二乙酰基-5’-脱氧-5-氟胞苷的制备方法
CN101830953A (zh) * 2010-05-26 2010-09-15 南京亚东启天药业有限公司 一种卡培他滨及其中间体的制备方法
US20130178614A1 (en) * 2011-10-25 2013-07-11 Virginia Tech Intellectual Properties, Inc. Regioselectively substituted cellulose esters and efficient methods of preparing them
TWI560195B (en) * 2012-01-13 2016-12-01 Pharmaessentia Corp Novel synthesis of 5-deoxy-5'-fluorocytidine compounds
CN103570781B (zh) * 2012-07-02 2016-01-13 国药一心制药有限公司 一种卡培他滨的工业化制备方法
EP2883959A1 (en) 2013-12-13 2015-06-17 Plasmia Biotech, S.L. Enzymatic production of cytosinic nucleoside analogues
CN103897006A (zh) * 2013-12-18 2014-07-02 吉林修正药业新药开发有限公司 一种卡培他滨异构体的制备方法
JP6950972B2 (ja) * 2016-06-28 2021-10-20 セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited ガンの処置のための組成物及び方法
EP4046989A1 (en) 2017-01-09 2022-08-24 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
EP3737376B1 (en) 2018-01-09 2024-04-17 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human diseases
KR20210057025A (ko) * 2018-08-03 2021-05-20 셀릭스 바이오 프라이빗 리미티드 암의 치료를 위한 조성물 및 방법
CN109651467A (zh) * 2019-01-15 2019-04-19 齐鲁天和惠世制药有限公司 一种卡培他滨杂质及其制备方法
CN111100172B (zh) * 2019-12-11 2023-03-17 中国科学院昆明植物研究所 一种胞嘧啶核苷衍生物及该衍生物制备卡培他滨药物的方法
WO2022049462A1 (en) * 2020-09-05 2022-03-10 Cellix Bio Private Limited Process for the preparation of derivatives of 5-fluoro pyrimidines used as anti cancer agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
ATE123289T1 (de) * 1988-12-07 1995-06-15 Yamasa Shoyu Kk Verbindungen von pyrimidin 2'-methylidin nukleosiden.
JPH0576898A (ja) * 1991-09-20 1993-03-30 Hitachi Kiden Kogyo Ltd スクリーン渣の破砕洗浄装置

Also Published As

Publication number Publication date
ES2093905T3 (es) 1997-01-01
KR100343481B1 (ko) 2002-11-23
RU2131879C1 (ru) 1999-06-20
ATE140923T1 (de) 1996-08-15
JPH07300492A (ja) 1995-11-14
CA2110335A1 (en) 1994-06-19
KR940014429A (ko) 1994-07-18
CN1095070A (zh) 1994-11-16
EP0602478A1 (en) 1994-06-22
EP0602478B1 (en) 1996-07-31
JP2004123758A (ja) 2004-04-22
CA2110335C (en) 2004-01-20
JP3530218B2 (ja) 2004-05-24
DE69303879D1 (de) 1996-09-05
DE69303879T2 (de) 1997-01-30
US5453497A (en) 1995-09-26
CN1035675C (zh) 1997-08-20
JP4202274B2 (ja) 2008-12-24
TW254946B (hr) 1995-08-21
DK0602478T3 (da) 1996-09-30

Similar Documents

Publication Publication Date Title
TW254946B (hr)
RU93055875A (ru) Новый способ получения производных n*994-ацил-5'-дезокси-5-флюороцитидина
HU9303296D0 (en) Process for diastereoselective synthesis of nucleosides
HUT46334A (en) Process for producing adenosine-5'-carboxamide derivatives
UA41261C2 (uk) Спосіб одержання збагачених бета-аномером нуклеозидів
TW291480B (hr)
IL111570A0 (en) Process for large scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
HUT61601A (en) Process for producing rebeccamycin analogs
PL274862A1 (en) Method of obtaining novel sugar derivatives
HK1009451A1 (en) Process for the synthesis of nucleoside analogues
CA2037783A1 (en) Rebeccamycin analogs by tryptophan analogs feeding
IL102144A0 (en) Process for producing 2'-deoxy-2',2'-difluoro nucleosides